Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
American Journal of Botany|March 24, 2025
Phylogenomics and biogeography of Guadua: Insights into a neotropical woody bamboo genusEduardo Ruiz-Sanchez, Carlos Maya-Lastra, María de la Luz Perez-Garcia, et al.
Plos One|August 19, 2021
TailTimer: A device for automating data collection in the rodent tail immersion assayMallory E Udell, Jie Ni, Angel Garcia Martinez, et al.
Plos One|August 12, 2014
Anti-human herpesvirus 6A/B IgG correlates with relapses and progression in multiple sclerosisIsabel Ortega-Madueño, Marta Garcia-Montojo, Maria Inmaculada Dominguez-Mozo, et al.
BMC Neurology|September 27, 2012
MHC2TA mRNA levels and human herpesvirus 6 in multiple sclerosis patients treated with interferon beta along two-year follow-upMaria Inmaculada Dominguez-Mozo, Marta Garcia-Montojo, Virginia De Las Heras, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|August 28, 2013
Anti-JCV antibodies detection and JCV DNA levels in PBMC, serum and urine in a cohort of Spanish Multiple Sclerosis patients treated with natalizumabMaria Inmaculada Dominguez-Mozo, Marta Garcia-Montojo, Virginia De Las Heras, et al.
Frontiers in Immunology|April 8, 2026
HERV-W association with serum biomarkers NfL and GFAP in multiple sclerosisStefano Ruberto, Maria I Dominguez-Mozo, Luisa María Villar, et al.
Frontiers in Psychiatry|March 3, 2022
Genome-Wide Association Study on Three Behaviors Tested in an Open Field in Heterogeneous Stock Rats Identifies Multiple Loci Implicated in Psychiatric DisordersMustafa Hakan Gunturkun, Tengfei Wang, Apurva S Chitre, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2010
CD46 in a Spanish cohort of multiple sclerosis patients: genetics, mRNA expression and response to interferon-beta treatmentRoberto Alvarez-Lafuente, Fiona Blanco-Kelly, Marta Garcia-Montojo, et al.
European Journal of Clinical Investigation|December 31, 2016
Study of the anti-JCV antibody levels in a Spanish multiple sclerosis cohortMaría I Dominguez-Mozo, Macarena Rus, Jose L Santiago, et al.
Frontiers in Immunology|June 24, 2024
A two-years real-word study with fingolimod: early predictors of efficacy and an association between EBNA-1 IgG titers and multiple sclerosis progressionMaria Inmaculada Dominguez-Mozo, Victoria Galán, Lluís Ramió-Torrentà, et al.
Pageof 3